EXPLAINER: New drug slows Alzheimer's but comes with caveats
A new Alzheimer's drug is hitting the market—the first with clear-cut evidence that it can slow, by several months, the mind-robbing disease.
Jan 8, 2023
0
9
A new Alzheimer's drug is hitting the market—the first with clear-cut evidence that it can slow, by several months, the mind-robbing disease.
Jan 8, 2023
0
9
A new USC Leonard Davis School of Gerontology study challenges existing ideas of how buildup of a protein called amyloid beta (Aβ) in the brain is related to Alzheimer's disease.
Jan 6, 2023
0
76
A new drug designed to ward off Alzheimer's is being tested at more than 100 sites around the world, including the University of Pennsylvania.
Dec 29, 2022
0
25
In November, researchers reported the drug lecanemab slowed the progression of Alzheimer's disease. The effect was modest, but it has generated tremendous excitement because it was the first time a drug had been shown to ...
Dec 27, 2022
0
107
Japan has approved a blood test kit to diagnose Alzheimer's disease, its manufacturer announced on Thursday, a rare advance in tackling a condition that affects tens of millions worldwide.
Dec 22, 2022
0
4
A new study led by Western Sydney University has shed new light on the treatment of Alzheimer's disease, after researchers identified proteins causing neuronal allergy in neurons treated with Alzheimer therapeutic antibodies.
Dec 15, 2022
0
26
Viruses can inflame and disrupt connections between the olfactory system, which governs the sense of smell, and the part of the brain associated with memory and learning, possibly accelerating the onset of Alzheimer's disease, ...
Dec 14, 2022
0
32
Amyloid plaques—protein clumps that are one of the hallmarks of Alzheimer's disease—occur at roughly the same level in the brains of people with Down syndrome who have Alzheimer's as they do in people with forms of hereditary, ...
Dec 13, 2022
0
45
Many neurodegenerative diseases, or conditions that result from the loss of function or death of brain cells, remain largely untreatable. Most available treatments target just one of the multiple processes that can lead to ...
Dec 8, 2022
0
20
Today, by and large, patients receive a diagnosis of Alzheimer's only after they exhibit well-known signs of the disease, such as memory loss. By that point, the best treatment options simply slow further progression of symptoms.
Dec 5, 2022
0
157